VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TCRXTScan Therapeutics, Inc.
$0.92$120M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTCRXPrice History

TCRX logoTScan Therapeutics, Inc. (TCRX) Stock Price History

Historical prices from 2021 to 2026

$0.92+0.02  (+2.23%)close Jun 18
Returns
1M
-8.0%
3M
-14.0%
YTD
-9.8%
1Y
-37.0%
3Y
-31.2%
5Y
-38.6%
ATH$14.71Aug 2021-93.7%
ATL$0.85Jun 2026pre-split
Avg Vol (50D)819K/ day
52-Week Range$0.85 — $2.57
LowCurrent: $0.92High

Loading 10-year price history...

TCRX Historical Performance

1 YearTotal Return
-37.0%
Price: -37.0%
3 YearsTotal Return
-67.5%
CAGR: -31.2%
Price: -67.5%
5 YearsTotal Return
-91.2%
CAGR: -38.6%
Price: -91.2%
YTD
-9.8%

TCRX Annual Returns

Year-by-year price performance · 2021–2026

Best+240.9%2023
Worst-67.6%2025
Up years2/6
2021-57.1%
2022-67.2%
2023+240.9%
2024-46.8%
2025-67.6%
2026+3.9%
2021 annual price return
-57.1%
2022 annual price return
-67.2%
2023 annual price return
+240.9%
2024 annual price return
-46.8%
2025 annual price return
-67.6%
2026 annual price return
+3.9%
LessMore
Alpha vs S&P 500
1Y-62.0%
3Y-51.3%
5Y-51.3%

Price returns only.

Download Historical Data

1,238 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

TCRX Stock Price Trajectory (2021–2026)

As of June 22, 2026, TScan Therapeutics, Inc. (TCRX) trades at $0.92, representing a -37.0% return over the past year. The stock has delivered a -91.2% total return over five years (-38.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $14.71 on August 18, 2021. From this peak, TCRX has corrected -93.7%, currently trading 27% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers IMVT (+122.8% 1Y), TCRT (-46.3% 1Y), and AGEN (-32.9% 1Y), TCRX has underperformed the peer group average. Compare TCRX vs IMVT →

TCRX Historical Price Data · from 2021

Rows 1–50 of 1,238
Date Open High Low Close Volume Change %
2026-06-180.910.930.870.92284K+2.23%
2026-06-170.850.940.850.90546K+4.00%
2026-06-160.940.950.860.87750K-8.95%
2026-06-150.951.000.930.9579K+4.20%
2026-06-120.920.960.910.91377K-1.28%
2026-06-110.940.960.900.92355K+0.59%
2026-06-101.001.020.910.92287K-4.87%
2026-06-091.011.030.960.97327K-2.86%
2026-06-080.991.010.970.99240K-0.61%
2026-06-051.031.030.971.00302K-1.96%
2026-06-040.981.030.961.02388K+4.94%
2026-06-031.001.010.940.97444K-0.82%
2026-06-020.991.070.970.98479K-2.97%
2026-06-011.081.081.011.01486K-6.48%
2026-05-291.091.101.061.08201K0.00%
2026-05-281.081.101.061.08292K+0.93%
2026-05-271.071.131.061.07507K0.00%
2026-05-261.051.081.041.07518K+0.94%
2026-05-221.041.081.001.060+3.92%
2026-05-210.991.040.981.02224K+2.55%
2026-05-200.981.020.960.99585K+3.27%
2026-05-190.981.000.960.96592K-3.69%
2026-05-181.001.020.971.00510K0.00%
2026-05-151.081.081.001.00839K-9.91%
2026-05-141.151.161.091.11867K-4.31%
2026-05-131.141.171.131.16356K+0.87%
2026-05-121.171.191.091.15883K-2.54%
2026-05-111.301.311.171.181.07M-6.35%
2026-05-081.231.341.231.261.28M+4.13%
2026-05-071.231.291.161.21802K-3.20%
2026-05-061.191.261.191.25978K+3.31%
2026-05-051.241.251.181.21930K-0.82%
2026-05-041.231.281.201.22452K0.00%
2026-05-011.161.241.141.22616K+5.17%
2026-04-301.151.201.141.16424K+0.87%
2026-04-291.251.251.131.15503K-8.73%
2026-04-281.251.321.251.26500K-3.82%
2026-04-271.251.351.251.31936K+3.97%
2026-04-241.231.261.171.261.07M+5.00%
2026-04-231.261.271.161.201.26M-4.00%
2026-04-221.281.321.231.25741K-1.57%
2026-04-211.401.401.261.271.28M-11.19%
2026-04-201.171.471.171.432.86M+20.17%
2026-04-171.121.201.111.191.24M+10.19%
2026-04-161.081.101.051.081.24M+0.93%
2026-04-151.051.071.031.07987K+0.94%
2026-04-141.031.071.021.061.21M+3.92%
2026-04-131.051.081.001.027.20M-2.86%
2026-04-101.061.091.011.051.12M-0.94%
2026-04-091.061.081.031.06665K0.00%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TCRX — Frequently Asked Questions

Quick answers to the most common questions about buying TCRX stock.

How has TCRX stock performed recently?

TCRX declined -37.0% over the past year, below its 5-year annualized CAGR of -38.6%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is TCRX's all-time high price?

TScan Therapeutics, Inc. reached $14.71 on 2021-08-18. The 52-week high is $2.57. Current 1-year return of -37.0% places the stock further from historical peaks.

Where can I download TCRX historical price data?

This page provides TCRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

414 data points · sampled from 1,238